These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26902725)

  • 21. Type I Interferon Counters or Promotes Coxiella burnetii Replication Dependent on Tissue.
    Hedges JF; Robison A; Kimmel E; Christensen K; Lucas E; Ramstead A; Jutila MA
    Infect Immun; 2016 Jun; 84(6):1815-1825. PubMed ID: 27068091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring pH of the Coxiella burnetii Parasitophorous Vacuole.
    Samanta D; Gilk SD
    Curr Protoc Microbiol; 2017 Nov; 47():6C.3.1-6C.3.11. PubMed ID: 29120485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated Cholesterol in the
    Mulye M; Samanta D; Winfree S; Heinzen RA; Gilk SD
    mBio; 2017 Feb; 8(1):. PubMed ID: 28246364
    [No Abstract]   [Full Text] [Related]  

  • 24. Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells.
    Fullerton MS; Colonne PM; Dragan AL; Brann KR; Kurten RC; Voth DE
    mSphere; 2021 Aug; 6(4):e0044221. PubMed ID: 34232075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MyD88 Is Required for Efficient Control of
    Kohl L; Hayek I; Daniel C; Schulze-Lührmann J; Bodendorfer B; Lührmann A; Lang R
    Front Immunol; 2019; 10():165. PubMed ID: 30800124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coxiella burnetii interaction with neutrophils and macrophages in vitro and in SCID mice following aerosol infection.
    Elliott A; Peng Y; Zhang G
    Infect Immun; 2013 Dec; 81(12):4604-14. PubMed ID: 24082077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of B cells in host defense against primary Coxiella burnetii infection.
    Schoenlaub L; Elliott A; Freches D; Mitchell WJ; Zhang G
    Infect Immun; 2015 Dec; 83(12):4826-36. PubMed ID: 26438792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of inflammasome activation by Coxiella burnetii type IV secretion system effector IcaA.
    Cunha LD; Ribeiro JM; Fernandes TD; Massis LM; Khoo CA; Moffatt JH; Newton HJ; Roy CR; Zamboni DS
    Nat Commun; 2015 Dec; 6():10205. PubMed ID: 26687278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coxiella burnetii as a useful tool to investigate bacteria-friendly host cell compartments.
    Pechstein J; Schulze-Luehrmann J; Lührmann A
    Int J Med Microbiol; 2018 Jan; 308(1):77-83. PubMed ID: 28935173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of lipids in Coxiella burnetii infection.
    Gilk SD
    Adv Exp Med Biol; 2012; 984():199-213. PubMed ID: 22711633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early cytokine and antibody responses against Coxiella burnetii in aerosol infection of BALB/c mice.
    Schoffelen T; Self JS; Fitzpatrick KA; Netea MG; van Deuren M; Joosten LA; Kersh GJ
    Diagn Microbiol Infect Dis; 2015 Apr; 81(4):234-9. PubMed ID: 25618420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coxiella burnetii stimulates production of RANTES and MCP-1 by mononuclear cells: modulation by adhesion to endothelial cells and its implication in Q fever.
    Meghari S; Desnues B; Capo C; Grau GE; Raoult D; Mege JL
    Eur Cytokine Netw; 2006 Dec; 17(4):253-9. PubMed ID: 17353158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent Coxiella burnetii infection in mice overexpressing IL-10: an efficient model for chronic Q fever pathogenesis.
    Meghari S; Bechah Y; Capo C; Lepidi H; Raoult D; Murray PJ; Mege JL
    PLoS Pathog; 2008 Feb; 4(2):e23. PubMed ID: 18248094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coxiella burnetii secretion systems.
    McDonough JA; Newton HJ; Roy CR
    Adv Exp Med Biol; 2012; 984():171-97. PubMed ID: 22711632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coxiella burnetii Infects Primary Bovine Macrophages and Limits Their Host Cell Response.
    Sobotta K; Hillarius K; Mager M; Kerner K; Heydel C; Menge C
    Infect Immun; 2016 Jun; 84(6):1722-1734. PubMed ID: 27021246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular pathogenesis of the obligate intracellular bacterium Coxiella burnetii.
    van Schaik EJ; Chen C; Mertens K; Weber MM; Samuel JE
    Nat Rev Microbiol; 2013 Aug; 11(8):561-73. PubMed ID: 23797173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host and Bacterial Factors Control Susceptibility of Drosophila melanogaster to Coxiella burnetii Infection.
    Bastos RG; Howard ZP; Hiroyasu A; Goodman AG
    Infect Immun; 2017 Jul; 85(7):. PubMed ID: 28438980
    [No Abstract]   [Full Text] [Related]  

  • 38. Fractionation of the Coxiella burnetii parasitophorous vacuole.
    Howe D; Heinzen RA
    Methods Mol Biol; 2008; 445():389-406. PubMed ID: 18425464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of innate immune signaling by a
    Burette M; Allombert J; Lambou K; Maarifi G; Nisole S; Di Russo Case E; Blanchet FP; Hassen-Khodja C; Cabantous S; Samuel J; Martinez E; Bonazzi M
    Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13708-13718. PubMed ID: 32482853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host cell depletion of tryptophan by IFNγ-induced Indoleamine 2,3-dioxygenase 1 (IDO1) inhibits lysosomal replication of Coxiella burnetii.
    Ganesan S; Roy CR
    PLoS Pathog; 2019 Aug; 15(8):e1007955. PubMed ID: 31461509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.